Compounds | FR50a | (%) Larval mortality | (%) Pupal mortality | (%) Emergency adults |
Control | - | 10 | 0 | 90 |
Squamocin | 0.66 ± 0.17 | 100 | 0 | 0 |
Molvizarin | 1.00 ± 0.15 | 100 | 0 | 0 |
Motrilin | 1.09 ± 0.15 | 80 | 15 | 5 |
Squamocin (3 OAc) | 0.77 ± 0.14 | 45 | 30 | 25 |
Molvizarin (3 OAc) | 1.21 ± 0.21 | 60 | 30 | 10 |
Motrilin (3 OAc) | 0.96 ± 0.15 | 80 | 0 | 20 |
Squamocin (MOM) | 0.95 ±0.15 | 15 | 0 | 85 |
Motrilin (MOM) | 0.98 ± 0.19 | 5 | 5 | 90 |